Fazel Shafie, Lawlor D Kirk, Forbes Thomas L
Division of Vascular Surgery, London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada.
Vasc Endovascular Surg. 2004 Mar-Apr;38(2):149-55. doi: 10.1177/153857440403800207.
The purpose of these authors' study was to analyze their center's experience with orthotopic heart transplantation (OHT) and abdominal aortic aneurysms (AAA) with particular attention to corticosteroid dosing, hemodynamic parameters, and aneurysm growth rate. A retrospective review of all patients (453) who underwent OHT at their university-affiliated medical center over an 18-year period (1981-1999) was undertaken. Nine (2%) patients who developed AAAs were identified and aneurysm growth was correlated with corticosteroid immunosuppression and hemodynamic parameters. The mean age of OHT patients was 44.5 +/-15 years and the majority were males (371 males, 82%). Median follow-up was 5.7 years. Ischemic cardiomyopathy (IC) was the most common indication for transplantation (45.5% of patients). All AAA patients were male (p=0.157), with a mean age of 58.4 +/-4.8 years (p=0.001), and had undergone OHT for IC (p=0.001). Mean arterial blood pressure and ejection fraction in the AAA patients had increased from pretransplant values of 107 mm Hg and 14.3 +/-5.7% to 142 mm Hg (p=0.017) and 54.1 +/-14.1% (p<0.001), respectively, before aneurysm repair. Mean aneurysm diameter at the time of repair was 6.0 +/-0.8 cm, and the average growth rate was 1.2 +/-0.4 cm/year in the 4 patients in whom it could be measured. Aneurysm repair was performed urgently in 2 patients and electively in 7 patients with 1 early postoperative death (11%). The extent of corticosteroid immunosuppression, corticosteroid pulses, and total corticosteroid dosing did not correlate with the rate of aneurysm growth. Improved hemodynamics and progressive posttransplant hypertension may contribute to aneurysm formation and growth in this group of patients.
这些作者开展此项研究的目的是分析其所在中心进行原位心脏移植(OHT)和腹主动脉瘤(AAA)的经验,尤其关注皮质类固醇的剂量、血流动力学参数和动脉瘤生长速率。对在其大学附属医院医疗中心18年期间(1981 - 1999年)接受OHT的所有患者(453例)进行了回顾性研究。确定了9例(2%)发生AAA的患者,并将动脉瘤生长与皮质类固醇免疫抑制和血流动力学参数进行了关联分析。OHT患者的平均年龄为44.5±15岁,大多数为男性(371例男性,82%)。中位随访时间为5.7年。缺血性心肌病(IC)是最常见的移植适应证(45.5%的患者)。所有AAA患者均为男性(p = 0.157),平均年龄为58.4±4.8岁(p = 0.001),并且因IC接受了OHT(p = 0.001)。在动脉瘤修复前,AAA患者的平均动脉血压和射血分数分别从移植前的107 mmHg和14.3±5.7%增加到了142 mmHg(p = 0.017)和54.1±14.1%(p < 0.001)。修复时动脉瘤的平均直径为6.0±0.8 cm,在可测量的4例患者中,平均生长速率为1.2±0.4 cm/年。2例患者紧急进行了动脉瘤修复,7例患者择期进行了修复,术后早期死亡1例(11%)。皮质类固醇免疫抑制的程度、皮质类固醇冲击治疗和皮质类固醇总剂量与动脉瘤生长速率无关。血流动力学改善和移植后进行性高血压可能促成了这组患者动脉瘤的形成和生长。